£47.6 M

Ergomed Revenue FY, 2017
Ergomed Gross profit (FY, 2017)14.6 M
Ergomed Gross profit margin (FY, 2017), %30.7%
Ergomed Net income (FY, 2017)-4.5 M
Ergomed EBITDA (FY, 2017)-2.3 M
Ergomed EBIT (FY, 2017)-3.9 M
Ergomed Cash, 31-Dec-20173.2 M

Ergomed Revenue

Ergomed revenue was £47.62 m in FY, 2017

Embed Graph

Ergomed Revenue Breakdown

Embed Graph

Ergomed revenue breakdown by business segment: 27.4% from Drug safety and medical information services and 72.6% from Clinical research services

Ergomed Income Statement

Annual

GBPFY, 2003FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

3 m4.3 m4.9 m7 m8.1 m9.6 m9.9 m12.1 m14.6 m15.1 m21.2 m30.2 m39.2 m47.6 m

Revenue growth, %

40%43%30%

Cost of goods sold

2.6 m3.4 m3.7 m5.7 m6 m6.4 m6.9 m8.1 m10.7 m10.1 m15.4 m21.8 m27.2 m33 m

Gross profit

404 k918.5 k1.2 m1.3 m2.1 m3.2 m3 m4 m3.9 m5 m5.8 m8.4 m12 m14.6 m

Gross profit Margin, %

13%22%24%19%26%33%30%33%27%33%27%28%31%31%

Operating expense total

112.7 k581.8 k892.6 k850.4 k2.1 m2.8 m2.7 m3.3 m3.5 m3.2 m5 m6.3 m11.9 m18.5 m

EBITDA

509.7 k169.3 k462.4 k370.8 k670.5 k522 k1.8 m852 k2.2 m1.1 m(2.3 m)

EBITDA margin, %

7%2%5%4%6%4%12%4%7%3%(5%)

EBIT

291.4 k336.6 k303.5 k494.9 k20.3 k357.7 k306.4 k619.7 k465 k1.8 m779 k2.1 m49 k(3.9 m)

EBIT margin, %

10%8%6%7%0%4%3%5%3%12%4%7%0%(8%)

Pre tax profit

299 k337.6 k306.3 k498.4 k(12.4 k)312.5 k308.9 k633.2 k474 k1.8 m777 k2.1 m(223 k)(4.4 m)

Income tax expense

(82.1 k)(103.1 k)(93.5 k)(154.6 k)(27.3 k)(188 k)(98.9 k)(98.4 k)(83 k)(232 k)(199 k)(520 k)153 k(57 k)

Net Income

216.8 k234.4 k212.9 k343.8 k(39.7 k)124.5 k209.9 k534.7 k391 k1.5 m578 k1.6 m(70 k)(4.5 m)

Ergomed Balance Sheet

Annual

GBPFY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3 k14.7 k668.9 k739.5 k143.2 k545.6 k452.5 k692.3 k467.9 k1 m642.2 k445 k2 m4.6 m4 m4.4 m3.2 m

Accounts Receivable

527.2 k867 k834 k1.8 m860.5 k2.1 m1.3 m3.1 m2.3 m2.3 m4.7 m6.4 m12.1 m15.8 m

Current Assets

3 k117.7 k1.3 m1.5 m1.3 m1.9 m3.1 m1.9 m3.1 m2.9 m4.4 m4 m5.2 m10.9 m13.5 m19.6 m23 m

PP&E

100 k86.4 k72.9 k58.3 k17 k476.1 k158.8 k175.7 k154.5 k164 k148 k185 k335 k717 k1.1 m

Goodwill

1.3 m10.2 m10.3 m32.1 m

Total Assets

3 k117.7 k1.4 m1.6 m1.4 m2 m3.3 m2.4 m3.4 m3.1 m4.5 m4.2 m6.7 m21.7 m24.7 m54.2 m61.9 m

Accounts Payable

253.2 k285.1 k240.1 k423.3 k653.4 k998.3 k834.8 k1.4 m2.4 m2.5 m2.7 m2.4 m3 m4.9 m

Current Liabilities

302 97.2 k1.1 m1.3 m1.1 m1.4 m2.5 m2.4 m3.1 m2.9 m3.8 m3.8 m4.8 m5.8 m7.2 m8.6 m13.9 m

Non-Current Liabilities

22.2 k17.8 k13.6 k9.3 k4.9 k18.9 k17.8 k9.4 k4.6 k31 k8 k581 k523 k11.2 m13.2 m

Total Debt

263 294.4 k46.3 k67 k22 k7 k5 k3 k

Total Liabilities

302 97.2 k1.1 m1.4 m1.1 m1.4 m2.5 m2.4 m3.1 m2.9 m3.8 m3.9 m4.8 m6.3 m7.8 m19.8 m27.1 m

Additional Paid-in Capital

2 2 2 2 2 1 k200 k200 k200 k200 k200 k200 k200 k288 k288 k406 k428 k

Retained Earnings

216.8 k84.4 k212.9 k143.8 k(119.7 k)124.5 k29.9 k534.7 k(409 k)1.5 m578 k1.6 m(70 k)(4.5 m)

Total Equity

2.7 k20.5 k237.4 k238.2 k322.6 k535.5 k750.7 k2.1 k258.6 k271 k746.5 k353 k1.9 m15.3 m16.9 m34.4 m34.8 m

Debt to Equity Ratio

0 x137.3 x0.2 x0.2 x0 x0 x0 x0 x

Debt to Assets Ratio

0 x0.1 x0 x0 x0 x0 x0 x0 x

Financial Leverage

1.1 x5.7 x5.8 x6.7 x4.3 x3.7 x4.4 x1.1 k x13 x11.6 x6.1 x12 x3.5 x1.4 x1.5 x1.6 x1.8 x

Ergomed Cash Flow

Annual

GBPFY, 2003FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

216.8 k234.4 k212.9 k343.8 k(39.7 k)124.5 k209.9 k534.7 k391 k1.5 m578 k1.6 m(70 k)(4.5 m)

Cash From Operating Activities

191.7 k334.4 k(339.2 k)969 k(361.9 k)581 k1.4 m537 k264 k(2.4 m)26 k

Dividends Paid

150 k200 k180 k800 k

Cash From Financing Activities

(36.1 k)(99.4 k)(351.7 k)(15.9 k)(710 k)(68 k)9.1 m(1 k)8.7 m2.7 m

Net Change in Cash

(92.8 k)161.8 k(224.4 k)572.3 k(398 k)(197 k)1.5 m2.6 m(602 k)450 k(1.2 m)

Income Taxes Paid

(232 k)(199 k)(520 k)153 k

Ergomed Ratios

GBPY, 2017

Revenue/Employee

317.5 k

Financial Leverage

1.8 x
Report incorrect company information

Ergomed Operating Metrics

Ergomed's Customers was reported to be 100 in FY, 2015.
FY, 2015

Countries

54

Customers

100

Patients Studied

30 k
Report incorrect company information